Journal ArticleOPEN ACCESS

Ceftazidime dosage regimen recommendations in burn patients based on a Monolix population pharmacokinetic study

  • Ruiz S
  • Conil J
  • Georges B
  • et al.
Critical Care (2012) 16(S1)
DOI: 10.1186/cc10673
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The aim of our present work was to predict in burn patients the best adapted ceftazidime dosage regimen to obtain a serum target of 40 to 100 mg/l taking into account the influence of patients' characteristics on ceftazidime pharmacokinetics (PK).

Cite

CITATION STYLE

APA

Ruiz, S., Conil, J., Georges, B., Ravat, F., Seguin, T., Letocart, P., … Saivin, S. (2012). Ceftazidime dosage regimen recommendations in burn patients based on a Monolix population pharmacokinetic study. Critical Care, 16(S1). https://doi.org/10.1186/cc10673

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free